D-FI
Dead / Abandoned — Abandoned — failure to respond (as of 30 May 2025)
What this means for you
This application is over — abandoned 14 May 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97149164
- Mark type
- Stylized text
- Filed
- 30 Nov 2021
- Published for opposition
- 16 May 2023
- Abandoned
- 14 May 2025
- Attorney of record
- Edward F. Behm, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy products, namely, genetically modified cells for medical use for the treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and injectable biological preparations containing genetically modified materials for treatment of dystrophic epidermolysis bullosa; Pharmaceutical preparations and therapeutic preparations for treatment of skin diseases, connective tissue diseases, arthritis and autoimmune diseases
Owner
- Castle Creek Biosciences, LLC, Exton, PA, US
- Castle Creek Biosciences, LLC, Exton, PA, US
Prosecution history
- 30 May 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 30 May 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 13 Feb 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 13 Feb 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 13 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Nov 2024 — NON-FINAL ACTION E-MAILED
- 13 Nov 2024 — SU - NON-FINAL ACTION - WRITTEN
- 29 Oct 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Jan 2024 — USE AMENDMENT FILED
- 30 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jan 2024 — SOU EXTENSION 1 GRANTED
- 11 Jan 2024 — SOU EXTENSION 1 FILED
- 29 Jan 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Jan 2024 — TEAS STATEMENT OF USE RECEIVED